KATEGORI
KATEGORI

Fudan University Shanghai Cancer Center (FUSCC)

Official Positioning: A national Grade-A tertiary cancer specialist hospital, one of the largest and most prestigious oncology medical, education and research bases in China.
Butiran Kes

Founded

March 1, 1931 (the earliest specialized cancer institution in China)

Affiliation

Affiliated to Fudan University; a budget-managed hospital under the NHC, and the National Cancer Medical Center (Shanghai).

Official Positioning

A national Grade-A tertiary cancer specialist hospital, one of the largest and most prestigious oncology medical, education and research bases in China.

Core Strengths & Flagship Specialties

1
5-year overall survival rate of cancer patients reaches 71.8%, reached the advanced level home and abroad.
2
Comprehensive oncology care system covering surgery, radiotherapy, chemotherapy, targeted therapy, immunotherapy, and proton & heavy ion therapy
3
National key disciplines: oncology and pathology, with leading advantages in breast cancer, lung cancer, gastrointestinal cancer, pancreatic cancer, head and neck tumors, and gynecologic oncology.
4
Advanced facilities: Da Vinci surgical robot, PET-MR, 5.0T MRI, and proton therapy system.

International Services & Cooperation

1
Dedicated international medical services for foreign patients, with English-speaking oncology specialists
2
Sister hospital partnership with MD Anderson Cancer Center (USA), and framework cooperation agreements with more than 10 world-renowned oncology institutions.
3
Publishes the international SCI-indexed journal Cancer Communications, with an impact factor of 24.9 (JCR Q1 zone).

Annual Service Volume

Over 2.3 million outpatient visits, more than 170,000 inpatient admissions, and over 76,000 surgical procedures annually.

Official Address

270 Dong'an Road, Xuhui District, Shanghai, China